Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.30 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.30 |
| ▸ | ITGAL | P20701 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16014653 | 0.74 | BACE1 (0.38) | — | |
| SCHEMBL21745512 | 0.72 | DAO (0.32) | DAOABCG2 | |
| SCHEMBL13254006 | 0.71 | KMT2A (0.45) | — | |
| SCHEMBL9148372 | 0.69 | MAPT (0.37) | — | |
| SCHEMBL20108444 | 0.69 | LPL (0.38) | — | |
| SCHEMBL13035632 | 0.68 | DAO (0.36) | DAO | |
| SCHEMBL2632864 | 0.66 | RARA (0.39) | — | |
| SCHEMBL29736073 | 0.65 | SIGMAR1 (0.45) | — | |
| SCHEMBL546544 | 0.65 | SIGMAR1 (0.45) | — | |
| Ammonia Solution, Strong SCHEMBL29163352 | 0.64 | SIGMAR1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11697695-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2023-07-11 | — | — | US | disclosed |
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| US-10479844-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2019-11-19 | — | — | US | disclosed |
| US-20190153125-A1 | POLYMERIZABLE COMPOSITION AND OPTICALLY ANISOTROPIC BODY USING SAME | DIC CORPORATION (JP) | 2019-05-23 | — | — | US | disclosed |
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | SMC4, PHOSPHO1, SMCHD1 | DAO 2020/4885NISCH 3836/4885ABCG2 2580/4885 |
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | SMC4, SMCHD1, PHOSPHO1 | DAO 2028/4885NISCH 3777/4885ABCG2 2480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.